Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A peppy response to PEPI results

Nature Medicine volume 1, pages 205–206 (1995)Cite this article

Recent publication of the results of the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial has led to the Woman's Health Initiative(WHI) to rethink the protocols for its own large trial.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Writing group for PEPI tria. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J.A.M.A. 273, 199–208 (1995).

  2. Grady, D. et al Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. intern. Med., 117, 1016–1037 (1992).

    Article  CAS  Google Scholar 

  3. Wentz, W.B. Progestin therapy in endometrial hyperplasia. Gynecol. Oncol. 2, 362–367 (1974).

    Article  CAS  Google Scholar 

  4. Smith, D.C., Prentice, R., Donovan, J.T. & Herrman, W.L. Association of exogenous estrogen and endometrial carcinoma. New Engl. J. Med. 293, 1164–1167 (1975).

    Article  CAS  Google Scholar 

  5. Ziel, H.K. & Finkle, W.D. Increased risk of endometrial carcinoma among users of conjugated estrogens. New Engl. J. Med. 293, 1167–1170 (1975).

    Article  CAS  Google Scholar 

  6. ACOG Technical Bulletin 166 (American College of Obstetricians and Gynecologists, Washington, DC, 1992).

  7. American College of Physicians. Ann. intern. Med. 117, 1038–1041 (1992).

  8. Woodruff, J.D. & Pickar, J.H. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am. J. Obstet. Gynecol. 170, 1213–1223 (1994).

    Article  CAS  Google Scholar 

  9. Simon, J.A. et al. The absorption of micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Obstet. Gynecol. 60, 26–33 (1993).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Woman's Health Initiative, Office of Research on Women's Health Office ofDisease Prevention National Insitutes of Health, Bethesda, Maryland, 20892-9110, USA

    Loretta P. Finnegan, Jacques Rossouw & William R. Harlan

Authors
  1. Loretta P. Finnegan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacques Rossouw
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William R. Harlan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finnegan, L., Rossouw, J. & Harlan, W. A peppy response to PEPI results. Nat Med 1, 205–206 (1995). https://doi.org/10.1038/nm0395-205

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0395-205

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing